Today, Bristol Myers Squibb announced new three-year overall survival data from its CheckMate -743 study. These data are based on the clinical trial of nivolumab/ipilimumab…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
